Portage Biotech Shares Are Trading Higher After the Company Announced the Spinoff of Its Subsidiary Cyncado Therapeutics.

BenzingaJan 14 22:02

Portage Biotech Re-Launches Subsidiary as Cyncado Therapeutics With New CEO

TipRanksJan 6 19:27

Portage: Cyncado to Focus on Advancing Clinical Development of A2a and A2b Receptor Antagonists to Achieve Proof-of-Concept Data for Its Therapeutics >PRTG

Dow JonesJan 6 18:35

Portage Biotech: Peter Molloy Appointed to Lead New Company >PRTG

Dow JonesJan 6 18:27

Portage Biotech: Adenosine Subsidiary to Become an Independently Managed Company >PRTG

Dow JonesJan 6 18:27

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

BenzingaDec 18, 2024 17:34